System And Method Of EAT/US-Guided Pulsed Field Ablation For Intracardiac Applications
Tech ID: 34331 / UC Case 2025-817-0
Brief Description
A real-time, ultrasound-based imaging modality that improves intracardiac
irreversible electroporation accuracy by visualizing electric field
distribution during cardiac ablation.
Full Description
Irreversible electroporation (IRE) is a nonthermal tissue ablation
technique that causes cell death in tissue while preserving the extracellular
matrix while inducing minimal inflammation, which makes it a promising
treatment for intracardiac ablations, however incomplete lesion treatment
leaves areas at risk of arrhythmic recurrence. This technology combines
electroacoustic tomography (EAT) with intracardiac echocardiography (ICE)
catheters to provide real-time imaging of electric field distributions during
irreversible electroporation (IRE) cardiac ablationwhich enables real-time
image guidance for cardiac ablation, minimizes collateral tissue damage, and
reduces repeat interventions for cardiac arrhythmias.
Suggested uses
- Cardiac ablation procedures: Guidance and monitoring of pulsed field
ablation (PFA) for arrhythmia treatment and intracardiac electroporation
therapies requiring precise lesion creation and verification.
- Clinical applications: Electrophysiology labs seeking improved ablation
success rates and reduced complications, particularly for pediatric and fragile
patients benefiting from nonthermal, targeted treatments.
- Advanced interventional solutions: Development of personalized cardiac
treatment devices and advanced imaging solutions for interventional cardiology
that optimize energy delivery.
Advantages
- Real-time precision and safety: Visualizes electric fields and
differentiates reversible vs. irreversible zones to ensure accurate lesion
formation and minimize collateral damage and also supports personalized
protocols and uses non-thermal ablation to avoid heat-sink effects, protecting
surrounding tissues and vessels.
- Reduced complexity: Provides immediate lesion verification and works
with standard ICE catheters, reducing repeat ablations.
Patent Status
Patent Pending